This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Nellwyn A Hagan: Innovator in Colony Stimulating Factor Inhibitors
Introduction
Nellwyn A Hagan is a notable inventor based in Canton, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for colony stimulating factor-1 receptors.
Latest Patents
Hagan holds 1 patent for his work on deuterated colony stimulating factor-1 receptor (CSF-1R) inhibitors. This patent discloses deuterated compounds that are useful as CSF-1R inhibitors, showcasing his innovative approach to addressing biological challenges.
Career Highlights
Hagan is associated with Genzyme Corporation, a leading biotechnology company known for its focus on rare diseases and innovative therapies. His work at Genzyme has positioned him as a key player in the development of therapeutic solutions.
Collaborations
Throughout his career, Hagan has collaborated with esteemed colleagues, including John L Kane, Jr and Maria A Fitzgerald. These partnerships have contributed to the advancement of research and development in his field.
Conclusion
Nellwyn A Hagan's contributions to the development of CSF-1R inhibitors highlight his innovative spirit and dedication to advancing biochemistry. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile